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The European Journal of Integrative Medicine (EuJIM) is
leased to announce to its readers that a new initiative begins
ith this issue – ‘Editor’s Choice’. Every issue, the Editor in
hief will choose one article which she feels showcases either
nnovation, originality or will have wider interest to the reader-
hip. The selected article will then be made Open Access and
ithout cost to the author. Already, the Editorials for each issue
re now Open Access so readers can access extra information
bout the breadth of articles provided in each issue. For this
ssue the article by Grundman and Yoon [1] has been chosen
s the Editor’s Choice for dissemination as the Open Access
ublication. This systematic review on Mind Body therapies for
unctional Bowel Disorders provides an excellent synthesis of
seful material on four common therapies which have great rele-
ance as self-help approaches and reflect an integrated approach
o care and management.
EuJIM  are  currently  also  inviting  submissions  for
two Special  issues  to  appear  later  this  year  enti-
tled ‘Clinical  Guidelines  for  Integrated  Practice’
and ‘Ensuring  and  Improving  Patients’  Safety  in
Integrative  Health  Care’.
Both  topics  are  of  key  interest  in  clinical  practice
particularly in  aiding  decision-making  for  opti-
mising safe  integrated  patient  care  and  both  rely
on robust  evidence.  For  further  details  please  visit
www.sciencedirect.com/science/journal/18763820.
Please note, The Guide for Authors has been updated so
efore you submit your article please see http://www.elsevier-
ata.de/journals/BM1.pdf for further details. We look forward
o receiving your articles but please remember to give the full
ames of all authors who should all provide their signed consent
nd must declare any conflicts of interest. It is important that any
rticle you submit should be proofed by a native English speaker
hich will help us by reducing both editorial and reviewer timend it will mean that your article will get published more quickly.
emember if your work describes the use of a natural product
 voucher specimen number is required and the supplier should
e identified.
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876-3820/$ – see front matter © 2013 Elsevier GmbH. All rights reserved.
ttp://dx.doi.org/10.1016/j.eujim.2013.05.002hoice’
Given this Editor’s Choice in this issue the focus of the
ditorial is functional bowel disorders (FBDs). FBDs are chal-
enging both to diagnose and to treat, particularly given that
hey include a spectrum of gastrointestinal dysfunction includ-
ng; Irritable Bowel Syndrome (IBS), functional abdominal pain,
unctional abdominal bloating, functional constipation, func-
ional diarrhoea and unspecified functional bowel disorder [2].
hese disorders are very common with the prevalence of Irritable
owel Syndrome (IBS), alone, quoted being between 5% and
0%. Interestingly, significant geographical variation has been
dentified: South America 21%, Northern Europe and Amer-
ca 12% and 7% in South East Asia. It affects more women
nd those under 50 years of age [3]. These geographical dif-
erences may potentially be related to how it is diagnosed in
ifferent countries. FBDs also cause significant impact upon
ork absenteeism and finances.
Confirming the diagnosis of function bowel disorders
equires the exclusion of pathology consistent with other diag-
oses such as inflammatory bowel disease, coeliac disease and
alignancy. Consequentially, in order to obtain a diagnosis
any patients undergo invasive and protracted investigations
which are not without their own associated morbidity) such
s upper and lower gastrointestinal endoscopy. This also high-
ights the significant associated healthcare costs diagnosing and
anaging functional bowel disorders.
The aetiology of FBDs is poorly understood, and as
 consequence, the majority of standard treatments focus
n managing symptoms. This includes; dietary changes,
axatives, anti-spasmodic agents (peppermint oil and mebev-
rine), anti-motility agents (loperamide) and antidepressants,
requently with limited benefit and often providing subopti-
al outcomes and leaving patients dissatisfied. Subsequent
o the failure of standard pharmacological management,
atients and some physicians then turn to mind-body thera-
ies.
In 2008, the UK National Institute of Health and Clinical
xcellence (NICE) produced clinical guidelines related to IBS
hich indicated the potential benefit from psychological thera-
ies for symptom management [4]. They identified the potential
mportance of approaches such as cognitive behavioural ther-
py, hypnotherapy and biofeedback but highlighted the paucity
f high quality trials, particularly evidence regarding cost
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ffectiveness which precluded them actively recommending
hem for routine use.
It is important to recognise the range of varying symptoms
ith FBDs and their associated severity. It could be argued
hat this reflects a collection of distinct conditions with differ-
ng aetiology. There is growing evidence to separate IBS from
ther functional bowel disorders identifying genetic, endocrine
ifference together with the expanding research regarding the
mpact of gut microbiota with regards to bowel dysfunction and
athology [5]. Examples of this include the fermentation and
smotic effects of fermentable oligosaccharides, disaccharides,
onosaccharides, and polyols (FODMAPs) present in the diet,
hich are thought to cause IBS symptoms [6]. In addition, the
mpact of the microbiome in IBS has been investigated in trials
sing minimally absorbed antibiotic rifaximin [7]. Furthermore,
 systematic review of probiotics in IBS identified improvements
n abdominal pain and bloating [8].
In this issue of the European Journal of Integrative Medicine,
he systematic review by Grundmann and Yoon on functional
owel disorders focusses on trials relating to common mind body
echniques; yoga, hypnotherapy, cognitive behavioural therapy
nd biofeedback [1]. Although studies are too heterogeneous
o be directly compared, the review suggests that there is some
ositive evidence from individual trials that patients who have
ot responded well to conventional treatment may benefit from
 mind body intervention. The strongest scientific evidence
ppears to be for the use of hypnosis for irritable bowel syn-
rome and other functional bowel disorders. However a criticism
f the studies examined in this review is that some studies used
he same mind-body intervention for a range of FBDs [1]. This
ay be inappropriate because if they were to be strictly defined
hey may be considered as diseases with differing aetiology. A
ecent randomised controlled trial has demonstrated that a sig-
ificant proportion of IBS patients reported adequate control of
heir symptoms with a placebo [9]. The authors stated that the
ffect of administering a placebo was likely to have “beneficial
ffects through mind-body self-healing processes”. These data
ay be highlighting the potential role of the mind-body with
egards to the perception of gastrointestinal disturbances and its
ontribution to the symptomatology of IBS.
Grundmann and Yoon have identified studies that indicate
ignificant, quantifiable improvement in the symptoms associ-
ted with functional bowel disorders, with the greatest evidence
elated to hypnotherapy [1]. However, the heterogeneity of the
vailable studies, often with lack of, or poor selection of control
nterventions limits their conclusions regarding the efficacy of
ind-body therapies for IBS. The lack of significant side effects
ssociated with mind body techniques is of particular impor-
ance. In light of our poor understanding of the pathophysiology
f functional bowel disorders and poor response to conventional
ietary and pharmacological treatment there is a true need for
igh quality trials examining the role of mind-body therapies in
unctional bowel disorders. Integrating mind body techniques
nto the self-management of functional bowel disorders may
herefore be a fruitful approach.
In addition to the above review there are three randomised
ontrolled trials reported in this issue [10–12]. Liu et al.’s
t
c
otive Medicine 5 (2013) 293–295
tudy on patients with moderate proteinuria resulting from IgA
ephropathy investigates the effect of adding a Chinese herbal
roduct (Zhengqingfengtongning) to a conventional angiotensin
eceptor blocker (ARB) [10]. Apart from a few minor side
ffects, the herbal product was well tolerated by patients, with
o significant adverse effects. This paper suggest that its addi-
ion to an ARB (Valsartin) may be significantly more effective
n controlling and treating moderate proteinurea as determined
y monitoring 24 hour protein compared with Valsartin alone.
Chronic obstructive pulmonary disease (COPD) is a prob-
em worldwide and is projected to become the third leading
ause of mortality by 2020.The goal for COPD management
s to improve mobility and health-related quality of life. In
rder to achieve this, patients’ self-efficacy (their perception
f their ability to perform an action) is an important indica-
or for health improvement, as well as their satisfaction with
he effectiveness of an intervention. Li et al. describe a multi-
entre, double-blind, double dummy, randomised controlled trial
f low-dose slow-release oral theophylline (or dummy) versus
u-Fei Yi-Shen granules (or dummy) orally administered twice
 day for 4 months; 0.2 g of the ointment of acupoint sticking
intment (or its dummy) applied to specific acupoints [11]. The
OPD Self-Efficacy Scale (CSES) and the Effectiveness Sat-
sfaction Questionnaire of COPD (ESQ-COPD) developed by
he authors were the outcomes used and the trial group demon-
trated increased improvement compared with controls for both
ver time. Frequency and duration of acute exacerbations and
mprovements in quality of life were reported together with ame-
ioration of symptoms. The paper also provides the rationale
or the acupoint selection which was based on TCM syndrome
ifferentiation. Bu-Fei Yi-Shen granules are made from highly
oncentrated, selected Chinese herbs and produced in accor-
ance with a traditional Chinese herbal formula they reduced the
xpression of interleukin (IL)-8, IL-6, IL-10, IL-1  and TNF-
 and regulating the level of inflammatory cytokines. Future
ork should concentrate on determining the dosing regimen and
uration of therapy.
Honey is a traditional remedy worldwide with a variety of
ealth related properties [13]. The Malaysian RCT in this issue
nvestigated the effect of honey administered orally to pregnant
ats. The authors postulate that these results may suggest a role
or Tualong honey in ameliorating the effects of stress during
regnancy and believe that it may have a possible role in foetal
eural development which may act to modulate pain responses
n later life [12]. This paper adds to the increasing number of
apers now appearing in the literature about honey and its uses
or health.
An observational study carried out on 113 hospitalised
orean patients over the age of 65 years demonstrates an asso-
iation between radial pulse signals and abnormal lipid profiles
14]. If sensitive enough, such a method could be used as a
reliminary screening instrument to assess for patients for poten-
ial cardiovascular disease. More detailed studies are needed
o determine whether this will be an important contribution to
linical practice.
The qualitative UK study compares the experiences
f patients and practitioners receiving acupuncture and
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omoeopathy offered in primary care (NHS) and private sett-
ngs [15]. The study uses both interviews and observation of
onsultations. For those experiencing both settings there was
ittle perceived difference in outcome as to where treatment
as provided or in its quality. The impact of shorter consul-
ation times on health outcomes within the NHS setting was
ot specifically studied and will be important to determine in
uture studies and whether this affects patients’ perceptions of
reatment effectiveness.
The importance of a patient’s own sense about belief of their
llness or ‘illness representation’ (IR) is likely to influence their
ehaviour during their illness and may act as a predictor of how a
atient manages a chronic condition. A Polish study focusses on
R and rheumatoid arthritis and suggests that making a decision
bout whether to receive acupuncture treatment is important in
etermining patient behaviour during the illness [16]. Although
he study’s limitations are discussed, there is evidence to suggest
hat IR is a significant predictor of willingness to use acupuncture
nd increases with age, and with greater personal control and
reatment control (i.e. the belief that they have little influence
ver the course of their diseases and that conventional treatment
s not successful enough).
In palliative care, a holistic approach is important if the physi-
al, psychological, spiritual and environmental needs of patients
re to be addressed by physicians. Frey et al. used in depth inter-
iews to explore the biomedical and holistic views of palliative
are with 7 physicians and highlight the importance of deliv-
ring whole person care which reflects the wishes of individual
atients [17]. Although a small study, the authors emphasise that
or patients with a chronic condition, adherence by physicians
o the traditional model of the disease state may be harmful and
oes not best reflect the wishes of the individual.
Multiple sclerosis (MS) is another chronic progressive con-
ition. Skovgaard et al.’s survey of members of the Danish MS
ociety demonstrated that 74% of respondents combined com-
lementary and alternative medicine (CAM) with conventional
edicine [18]. Those with conditions other than MS were more
ikely to use CAM, usually for specific purposes and more often
erbal medicine. Those using CAM were also more likely to be
n a special diet and report higher self-assessed quality of life.
The importance of healing touch in an emergency setting after
cute admission is described in a qualitative study by Airosa et al.
19]. This Swedish study focusses on tactile and healing touch
rovided to 25 patients. The interviews emphasise the complex-
ty in of providing caring touch at times of trauma. The integrated
ealth approaches should be considered within a wider scope of
linical practice.
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